Social Phobia Clinical Trial
— SOFIE13aOfficial title:
Reduction of Social Phobia Symptoms With Combined Internet-Based Cognitive Bias Modification and Cognitive Behavioral Therapy
Verified date | October 2016 |
Source | Umeå University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Sweden: Regional Ethical Review Board |
Study type | Interventional |
The purpose of this study is to determine whether an internet-based treatment program, consisting of combined cognitive bias modification and cognitive behavioral therapy, reduces symptoms of social phobia among a population diagnosed with this disorder.
Status | Completed |
Enrollment | 133 |
Est. completion date | December 2014 |
Est. primary completion date | September 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Written informed consent provided - Diagnosed social phobia (according to DSM-IV criteria) - Access to computer with internet connection Exclusion Criteria: - Severe depression (and/or suicidal behavior) - Suffer from other severe psychiatric condition (e.g. psychosis) - Non-stable use of medication (3 months stable dosage) - Undergoing other, parallel psychological treatment |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Sweden | Department of Psychology, Umeå University | Umeå | Västerbotten |
Lead Sponsor | Collaborator |
---|---|
Umeå University |
Sweden,
Boettcher J, Andersson G, Carlbring P; SOFIE-13 Research Group. Combining attention training with cognitive-behavior therapy in Internet-based self-help for social anxiety: study protocol for a randomized controlled trial. Trials. 2013 Mar 8;14:68. doi: 10.1186/1745-6215-14-68. — View Citation
Boettcher J, Hasselrot J, Sund E, Andersson G, Carlbring P. Combining attention training with internet-based cognitive-behavioural self-help for social anxiety: a randomised controlled trial. Cogn Behav Ther. 2014;43(1):34-48. doi: 10.1080/16506073.2013.8 — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline in Liebowitz Social Anxiety Scale Self-Rated (LSAS-SR) | The Liebowitz Social Anxiety Scale (LSAS) is a questionnaire by psychiatrist and researcher, Michael Liebowitz, whose objective is to assess the range of social interaction and performance situations which patients with social anxiety disorder may fear. It is commonly used to study outcomes in clinical trials. The scale features 24 items, 13 relating to performance anxiety and 11 concerning social situations. It is not intended for use as a self-reporting diagnosis. | 24 hours | No |
Primary | Change from baseline in Liebowitz Social Anxiety Scale Self-Rated (LSAS-SR) | The Liebowitz Social Anxiety Scale (LSAS) is a questionnaire by psychiatrist and researcher, Michael Liebowitz, whose objective is to assess the range of social interaction and performance situations which patients with social anxiety disorder may fear. It is commonly used to study outcomes in clinical trials. The scale features 24 items, 13 relating to performance anxiety and 11 concerning social situations. It is not intended for use as a self-reporting diagnosis. | 11 weeks | No |
Primary | Change from baseline in Liebowitz Social Anxiety Scale Self-Rated (LSAS-SR) | The Liebowitz Social Anxiety Scale (LSAS) is a questionnaire by psychiatrist and researcher, Michael Liebowitz, whose objective is to assess the range of social interaction and performance situations which patients with social anxiety disorder may fear. It is commonly used to study outcomes in clinical trials. The scale features 24 items, 13 relating to performance anxiety and 11 concerning social situations. It is not intended for use as a self-reporting diagnosis. | 4 months | No |
Primary | Change from baseline in Liebowitz Social Anxiety Scale Self-Rated (LSAS-SR) | The Liebowitz Social Anxiety Scale (LSAS) is a questionnaire by psychiatrist and researcher, Michael Liebowitz, whose objective is to assess the range of social interaction and performance situations which patients with social anxiety disorder may fear. It is commonly used to study outcomes in clinical trials. The scale features 24 items, 13 relating to performance anxiety and 11 concerning social situations. It is not intended for use as a self-reporting diagnosis. | Two weeks into treatment | No |
Secondary | Change from baseline in Quality Of Life Inventory (QOLI) | The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play. The QOLI test is a measure of positive psychology and positive mental health. | 24 hours | No |
Secondary | Change from baseline in Quality Of Life Inventory (QOLI) | The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play. The QOLI test is a measure of positive psychology and positive mental health. | 11 weeks | No |
Secondary | Change from baseline in Quality Of Life Inventory (QOLI) | The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play. The QOLI test is a measure of positive psychology and positive mental health. | 4 months | No |
Secondary | Change from baseline in Quality Of Life Inventory (QOLI) | The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play. The QOLI test is a measure of positive psychology and positive mental health. | 2 weeks into treatment | No |
Secondary | Change from baseline in Social Phobia Scale + Social Interaction Anxiety Scale | Self-rated measurements of social anxiety/phobia. | 24 hours | No |
Secondary | Change from baseline in Social Phobia Scale + Social Interaction Anxiety Scale | Self-rated measurements of social anxiety/phobia. | 11 weeks | No |
Secondary | Change from baseline in Social Phobia Scale + Social Interaction Anxiety Scale | Self-rated measurements of social anxiety/phobia. | 4 months | No |
Secondary | Change from baseline in Social Phobia Scale + Social Interaction Anxiety Scale | Self-rated measurements of social anxiety/phobia. | 2 weeks into treatment | No |
Secondary | Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) | 9-item depression rating scale. | 24 hours | No |
Secondary | Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) | 9-item depression rating scale. | 11 weeks | No |
Secondary | Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) | 9-item depression rating scale. | 4 months | No |
Secondary | Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) | 9-item depression rating scale. | 2 weeks into treatment | No |
Secondary | Change from baseline in mini-SPIN | Mini-SPIN is a three-item self-rating scale for assessment of symptoms of social phobia using a five-point Likert scale. | Daily, 1-15 days into treatment | No |
Secondary | Change from baseline in mini-SPIN | Mini-SPIN is a three-item self-rating scale for assessment of symptoms of social phobia using a five-point Likert scale. | 11 weeks | No |
Secondary | Change from baseline in mini-SPIN | Mini-SPIN is a three-item self-rating scale for assessment of symptoms of social phobia using a five-point Likert scale. | 4 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02256566 -
Cognitive Training for Mood and Anxiety Disorders
|
N/A | |
Recruiting |
NCT01388231 -
Transfer of Manualized Cognitive-Behavioral Therapy (CBT) for Social Phobia Into Clinical Practice
|
Phase 2/Phase 3 | |
Completed |
NCT00684541 -
Interpretation Modification Program for Social Phobia
|
N/A | |
Completed |
NCT00380731 -
Effect of Behavior Therapy on Responses to Social Stimuli in People With Social Phobia
|
N/A | |
Completed |
NCT00434759 -
Social Phobia Intervention Study of Mannheim
|
N/A | |
Completed |
NCT03647605 -
Pilot Study: VR Mind and VR Mind+ Intervention
|
N/A | |
Not yet recruiting |
NCT03241277 -
Nonsurgical Periodontal Treatment in Patients With Social Phobia
|
N/A | |
Completed |
NCT02648737 -
Cognitive Behavioural Therapy for Anxiety Disorders in PD
|
N/A | |
Completed |
NCT02294409 -
Manualized Group Cognitive-behavioral Therapy for Social Anxiety in First Episode Psychosis
|
N/A | |
Terminated |
NCT01979263 -
Attention Bias Modification Treatment for Anxious Youth
|
N/A | |
Completed |
NCT01463137 -
Attention Bias Modification Training in Social Phobia/Social Anxiety Disorder
|
N/A | |
Completed |
NCT00774150 -
Transdisciplinary Studies of CBT for Anxiety in Youth: Child Anxiety Treatment Study
|
N/A | |
Completed |
NCT00264654 -
Long-term Study Of Paroxetine in Women and Men
|
Phase 3 | |
Completed |
NCT00326430 -
Residential Cognitive and Interpersonal Therapy for Social Phobia
|
Phase 2/Phase 3 | |
Completed |
NCT00000389 -
Treatment for Anxiety in Children
|
Phase 3 | |
Completed |
NCT00397722 -
Treatment Of Patients With Social Anxiety Disorder
|
Phase 2 | |
Completed |
NCT02678624 -
Project Collabri for Treatment of Anxiety
|
N/A | |
Completed |
NCT00564967 -
A Comparison Between Internet Therapy and Group Therapy for Social Phobia - A Trial Using Cognitive Behavioural Therapy
|
Phase 3 | |
Completed |
NCT00403962 -
A Combination Therapy In Patients With Social Anxiety Disorder
|
Phase 2 | |
Completed |
NCT00012584 -
Treatment of Youth With ADHD and Anxiety
|
N/A |